Researchers report that targeting inflammation may offer a new way to treat depression. The study focused on people with depression who had high levels of inflammation. The team reviewed clinical trials in which participants received anti-inflammatory drugs or a placebo.
Overall, anti-inflammatory treatments reduced depressive symptoms and eased anhedonia, the inability to feel pleasure. The analysis also found no increase in serious side effects among people who received the drugs.
The authors noted these drugs are not approved by the FDA to treat depression, so psychiatric use would be off-label. One co-author said the result may make immunopsychiatry more relevant and could explain earlier mixed findings when studies did not select people by inflammatory status.
Difficult words
- inflammation — body reaction that causes redness or swelling
- anhedonia — not being able to feel pleasure
- placebo — a fake medicine given in a study
- clinical trial — a medical study that tests treatmentsclinical trials
- side effect — an unwanted medical problem from a drugside effects
- immunopsychiatry — study of immune system links to mental illness
- off-label — use of a drug not officially approved
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Would you try an anti-inflammatory drug for depression if a doctor suggested it? Why or why not?
- Why do the authors think earlier studies had mixed findings?
- How could anhedonia change a person's daily life?
Related articles
New device measures blood viscosity in real time
Researchers at the University of Missouri created a non-invasive device that monitors blood viscosity and density in real time using ultrasound and software. It can read blood without drawing samples and may help in diseases like sickle cell.
New drug pair helps fight rifampicin-resistant tuberculosis
Scientists paired rifampicin with a probe called AAP-SO2 that binds bacterial RNA polymerase at a different site and slows transcription. The pair killed resistant mutants in culture and was especially effective in a rabbit model.
